Pharmacovigilance capacity and readiness of vaccine manufacturers in low- and middle-income countries: a maturity-based assessment of the pharmacovigilance system.
- DOI
- 10.1016/j.vaccine.2026.128481
- Published
- 2026-03-18
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.128481,
title = {Pharmacovigilance capacity and readiness of vaccine manufacturers in low- and middle-income countries: a maturity-based assessment of the pharmacovigilance system.},
author = {de Oliveira PMN and Bosman R and Lucchesi MBB and Ogar C and Pedro RS and Hartmann K.},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.128481},
url = {https://doi.org/10.1016/j.vaccine.2026.128481}
}RIS
TY - JOUR TI - Pharmacovigilance capacity and readiness of vaccine manufacturers in low- and middle-income countries: a maturity-based assessment of the pharmacovigilance system. AU - de Oliveira PMN AU - Bosman R AU - Lucchesi MBB AU - Ogar C AU - Pedro RS AU - Hartmann K. PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2026.128481 UR - https://doi.org/10.1016/j.vaccine.2026.128481 ER -
APA
PMN, D. O., R, B., MBB, L., C, O., RS, P., & K., H. (2026). Pharmacovigilance capacity and readiness of vaccine manufacturers in low- and middle-income countries: a maturity-based assessment of the pharmacovigilance system.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128481
Source records
- europe-pmc · retrieved 2026-09-27T09:38:47.709Z